Mitsubishi Tanabe Pharma America, Inc.
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focusesOn |
neurology
rare diseases |
| gptkbp:foundedIn |
2016
|
| gptkbp:headquartersLocation |
gptkb:Jersey_City,_New_Jersey,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Radicava
|
| gptkbp:parentCompany |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
|
| gptkbp:subsidiary |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
|
| gptkbp:website |
https://www.mt-pharma-america.com/
|
| gptkbp:bfsParent |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma America, Inc.
|